ArticleJournal of hematology & oncology2018

Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL.

Shuhua Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.